TABLE 4.
Mold-active antifungal agent use in patients with false-positive and true-negative galactomannan test
| Indication | Antifungal agent (no. of patients)a |
|---|---|
| Patients with true-negative tests | |
| Prophylaxis | Abelcet (7) |
| Empiric therapy | AmB and then Abelcet (2), Abelcet (1) |
| Established infections | |
| Granulomas in the donor liver | AmB (1) |
| Candida peritonitis | Abelcet (3) |
| Torulopsis glabrata fungemia | Abelcet (1) |
| Patients with false-positive tests | |
| Empiric therapy | Abelcet (2), AmB (1) |
| Established infection | |
| Disseminated histoplasmosis | Abelcet (1) |
| Candida peritonitis | Abelcet (1) |
a
Abelcet, amphotericin B lipid complex; AmB, amphotericin B deoxycholate.